Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 197.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,037 shares of the medical instruments supplier's stock after buying an additional 32,566 shares during the quarter. Teacher Retirement System of Texas' holdings in DENTSPLY SIRONA were worth $1,745,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. VisionPoint Advisory Group LLC boosted its stake in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock valued at $26,000 after buying an additional 395 shares during the period. Principal Securities Inc. purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Headlands Technologies LLC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust increased its position in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier's stock worth $42,000 after purchasing an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in DENTSPLY SIRONA in the fourth quarter valued at approximately $47,000. 95.70% of the stock is currently owned by institutional investors.


DENTSPLY SIRONA Stock Down 0.4 %

Shares of DENTSPLY SIRONA stock traded down $0.10 on Friday, reaching $28.28. The company's stock had a trading volume of 2,196,809 shares, compared to its average volume of 3,262,339. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -64.27, a P/E/G ratio of 1.25 and a beta of 1.00. The firm's fifty day simple moving average is $31.08 and its two-hundred day simple moving average is $32.48. DENTSPLY SIRONA Inc. has a 52 week low of $26.27 and a 52 week high of $41.65. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts' consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company's quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA's dividend payout ratio is currently -145.45%.

Analysts Set New Price Targets

Several research firms have recently weighed in on XRAY. Leerink Partnrs restated an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Barrington Research cut their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an "outperform" rating for the company in a report on Friday, May 3rd. SVB Leerink started coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an "outperform" rating and a $42.00 price objective on the stock. The Goldman Sachs Group reduced their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a "neutral" rating on the stock in a research note on Monday, May 6th. Finally, Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an "outperform" rating on the stock in a research note on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $35.22.

Read Our Latest Report on XRAY

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: